Possible mechanisms mediating an association between physical activity and breast cancer

Cancer

Volumn 83, Issue 3 SUPPL., 1998, Pages 621-628

  Hoffman Goetz, Laurie ^a   Apter, Dan ^b   Demark Wahnefried, Wendy ^c   Goran, Michael I ^d   McTiernan, Anne ^e   Reichman, Marsha E ^f  

^a UNIVERSITY OF WATERLOO   (Canada)

^b Dept of Obstetrics and Gynecology ^*  (Finland)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e USA   (United States)

^f ROW Sciences Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY WEIGHT; BREAST CANCER; CANCER RISK; CONFERENCE PAPER; ENERGY BALANCE; ENERGY EXPENDITURE; FITNESS; HORMONAL REGULATION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MENSTRUAL CYCLE; OVARY FUNCTION; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 0032147259     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19980801)83:3+<621::aid-cncr4>3.0.co;2-a     Document Type: Conference Paper

References (106)

1. Friedenreich C, Thune I, Brinton LA, Albanes D. Epidemiologic issues related to the association between physical activity and breast cancer. Cancer 1998;83:600-10.
2. Ainsworth B, Sternfeld B, Slattery M, Daguise V, Zahm SH. Physical activity and breast cancer: evaluation of physical activity assessment methods. Cancer 1998;83:611-20.
3. Hoffman-Goetz L, Apter D, Demark-Wahnefried W, Goran M, McTiernan A, Reichman ME. Possible mechanisms mediating an association between physical activity and breast cancer. Presented at the National Action Plan on Breast Cancer's Workshop on Physical Activity and Breast Cancer, Albuquerque, New Mexico, November 13-14, 1997.
4. Henderson BE, Bernstein L. The international variation in breast cancer rates: an epidemiological assessment. Breast Cancer Res Treat 1991;18(Suppl 1):S11-7.
5. Soini I. Risk factors of breast cancer in Finland. Int J Epiclemiol 1977;6:366-73.
6. La Vecchia C, Decarli A, Di Pietro S, Franceschi S, Negri E, Parazzini F. Menstrual cycle patterns and the risk of breast disease. Eur J Cancer Clin Oncol 1985;21:417-22.
7. Bernstein L, Ross RK, Lobo RA, Hanish R, Krailo MD, Henderson BE. The effects of moderate physical activity on menstrual cycle patterns in adolescence: implications for breast cancer prevention. Br J Cancer 1987;55:681-5.
8. Vihko RK, Apter DL. The epidemiology and endocrinology of the menarche in relation to breast cancer. Cancer Surv 1986; 5:561-71.
9. Pike MC, Henderson BE, Casagrande IT. The epidemiology of breast cancer as it relates to menarche, pregnancy and menopause. In: Pike MC, Siiter PK, Welsh C, editors. Hormones and breast cancer. Banbury Report No 8. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory, 1981:3-13.
10. Apter D. Hormonal events during female puberty in relation to breast cancer risk. Eur J Cancer Prev 1996;5:476-82.
11. Frisch RE. Fatness, menarche and female fertility. Perspect Biol Med 1985;28:611-33.
12. Drinkwater BL, Nilson K, Chesnut CH III, et al. bone mineral content of amenorrheic and eumenorrheic athletes. N Engl J Med 1984;311:277-81.
13. Ellison PT. Salivary steroids and natural variation in human ovarian function [review]. Ann N Y Acad Sci 1994;709:287-98.
14. Ellison PT, Panter BC, Lipson SF, O'Rourke MT. The ecological context of human ovarian function. Hum Reprod 1993; 8:2248-58.
15. Panter BC, Lotstein DS, Ellison PT. Seasonality of reproductive function and weight loss in rural Nepali women. Hum Reprod 1993;8:684-90.
16. Russo J, Russo IH. Role of differentiation in the pathogenesis and prevention of breast cancer. Endocr-Relat Cancer 1997; 4:7-21.
17. Colditz GA, Frazier AL. Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus. Cancer Epidemiol Biomarkers Prev 1995;4:567-71.
18. Thune I, Brenn T, Lund E, Gaard M. Physical activity and the risk of breast cancer. N Engl J Med 1997;336:1269-75.
19. Loucks AB, Heath EM. Dietary restriction reduces luteinizing hormone (LH) pulse frequency during waking hours and increases LH pulse amplitude during sleep in young menstruating women. J Clin Endocrinol Metab 1994;78:910-5.
20. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet 1996;347:1713-27.
21. Dorgan IF, Longcope C, Stephenson HJ, Falk RT, Miller R, Franz C, et al. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol Biomarkers Prev 1996;5:533-9.
22. Cauley JA, Gutai JP, Juller LH, et al. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 1989;129:1120-31.
23. Nelson ME, Meredith CN, Dawson-Hughes B, Evans WJ. Hormone and bone mineral status in endurance-trained and sedentary postmenopausal women. J Clin Endocrinol Metab 1988;66:927-33.
24. Apter D. Serum steroids and pituitary hormones in female puberty: a partly longitudinal study. Clin Endocrinol 1980; 12:107-20.
25. Campbell BC, Ellison PT. Menstrual variation in salivary testosterone among regularly cycling women. Horm Res 1992;37:132-6.
26. Vihko R, Apter D. Endogenous steroids in the pathophysiology of breast cancer. Crit Rev Oncol Hematol 1989;9:1-16.
27. Casey RW, Wilson JD. Antiestrogenic action of dihydrotestosterone in mouse breast. Competition with estradiol for binding to the estrogen receptor. J Clin Invest 1984;74:2272-8.
28. Danforth E Jr. Regulation of energy expenditure. In: Belfore F, Jeanrenaud 13, Papalia D, editors. Obesity. Basic concepts and clinical aspects. Basel: S. Karger, 1991;61-77.
29. Ravussin E, Lillioja S, Anderson TE, Christin L, Bogardus C. Determinants of 24-hour energy expenditure in man. Methods and results using a respiratory chamber. J Clin Invest 1986;78:1568-78.
30. Golan M. Variation in total energy expenditure in humans. Obesity Res 1995;3:59-66.
31. Flatt JP. Dietary fat, carbohydrate balance, and weight maintenance. Ann N Y Acad Sci 1993;683:12240.
32. Despres JP, Allard C, Tremblay A, Talbot J, Bouchard C. Evidence for a regional component of body fatness in the association with serum lipids in men and women. Metabolism 1985;34:967-73.
33. Despres JP, Lemieux S, Lamarche B, Prud'homme D, Moorjani S, Brun LD. The insulin resistance-dyslipidemic syndrome: contribution of visceral obesity and therapeutic implications. Int J Obes Relat Metab Disord 1995;19:s76-s86.
34. Bjorntorp P. Abdominal fat distribution and disease: an overview of epidemiological data. Ann Med 1992;24:15-8.
35. Hunter GR, Kekes-Szabo T, Treuth MS, Williams MJ, Golan M, Pichon C. Intra-abdominal adipose tissue, physical activity and cardiovascular risk in pre-and post-menopausal women. Int J Obes Relat Metab Disord 1996;20:860-5.
36. Chie WC, Chen CF, Lee WC, Chen CJ. Body size and risk of pre-and post-menopausal breast cancer in Taiwan. Anticancer Res 1996;16(5B):3129-32.
37. Hunter DJ, Willett WC. Diet, body size, and breast cancer. Epidemiol Rev 1993:15(1):110-32.
38. Swanson CA, Coates RJ, Schoenberg JB, Malone KE, Gammon MD, Stanford JL, et al. Body size and breast cancer risk among women under age 45 years. Am J Epidemiol 1997; 145(7):669-70.
39. Ballard-Barbash R. Anthropometry and breast cancer: body size-a moving target. Cancer 1994;74:1090-100.
40. Ballard-Barbash R. Perspectives on integrating experimental and epidemiologic research on diet, anthropometry and breast cancer. J Nutr 1997;127(5 Suppl):936S-39S.
41. Huang Z, Hankinson SE, Colditz GA, et al. Dual effects of weight and weight gain on breast cancer risk. JAMA 1997; 278:1407-11.
42. Willett WC, Browne ML, Bain C, Lipnick RI, Stampfer MJ, Rosner B, et al. Relative weight and risk of breast cancer among premenopausal women. Am J Epidemiol 1985;122: 731-40.
43. Cooper GS, Sandler DP, Whelan EA, Smith KR. Association of physical and behavioral characteristics with menstrual cycle patterns in women age 29-31 years. Epidemiology 1996;7:624-8.
44. Boyd NF, Campbell JE, Germanson T, Thompson OB, Sutherland DJ, Meakin JW. Body weight and prognosis in breast cancer. J Natl Cancer Inst 1981;67:785-9.
45. Maehle BO, Tretli S. Pre-morbid body-mass-index in breast cancer reversed effect on survival in hormone receptor negative patients. Breast Cancer Res Treat 1996;41:123-40.
46. Senie RT, Rosen PP, Rhodes P, Lesser M, Kinne DW. Obesity at diagnosis of breast carcinoma influences duration of disease free survival. Ann Intern Meet 1992;116:26-32.
47. Stoll BA. Diet and exercise regimens to improve breast carcinoma prognosis. Cancer 1996;78:2466-70.
48. Tartter PJ, Papatestas AE, Ionnovich J, Mulvihill MN, Lesnick G, Aulses AH. Cholesterol and obesity as prognostic factors in breast cancer. Cancer 1981;47:2222-7.
49. Tretli S, Haldorson T, Ottestad L. The effect of premorbid height and weight on the survival of breast cancer patients. Br J Cancer 1990;62:299-303.
50. Camoriano JK, Loprinzi CL, Ingle JN, et al. Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol 1990;8:1327-34.
51. Demark-Wahnefried W, Rimer BK, Winer EP. Weight gain in women diagnosed with breast cancer. J Am Diet Assoc 1997; 97:519-26, 529.
52. Demark-Wahnefried W, Winer EP, Rimer SK. Why women gain weight with adjuvant chemotherapy for breast cancer. J Clin Oncol 1993;11:1418-29.
53. Tannenbaum A. Relationship of body weight to cancer incidence. Arch Pathol Lab Med 1940;30:509-15.
54. Willett WC. Fat, energy and cancer. J Nutr 1997;127:921S-3S.
55. Bruning PF, Bonfree JB, vanNoord PA, deJong-Bakker M, Nooijen WI. Insulin resistance and breast-cancer risk.. Int J Cancer 1992;52:511-6.
56. Gamayunova VB, Bobrov YF, Tsyrlina EV, Evtushenko TP, Berstein LM. Comparative study of blood insulin levels in breast and endometrial cancer patients. Neoplasma 1997;44: 123-6.
57. Moller DE, Flier IS. Insulin resistance-mechanisms, syndromes, and implications. N Engl J Med 1991;325:938-48.
58. Goodwin PJ, Boyd NF, Hanna W, Hartwick W, Murray D, Oizilbash A, et al. Elevated levels of plasma triglycerides are associated with histologicaily defined premenopausal breast cancer risk. Nutr Cancer 1997;27:284-92.
59. Maggino T, Marcadella CB, Romagnolo C. The role of insulin and renin in the pathogenesis of hormone-dependent neoplasias. Eur J Gynaecol Oncol 1993;14:131-4.
60. Stoll BA, Secreto G. Prenatal influences and breast cancer. Lancet 1992;340(8833):1478.
61. Frisch RE, Gotz-Welbergen AV, McArthur JW, Albright T, Witschi J, Bullen B, et al. Delayed menarche and amenorrhea of college athletes in relation to age of onset of training. JAMA 1981;246:1559-63.
62. Frisch RE, Wyshak G, Albright NL, Albright TE, Schiff L, Jones JP, et al. Lower prevalence of breast cancer and cancers of the reproductive system among former college athletes compared to non-athletes. Br J Cancer 1985;52:88-91.
63. Mersenich H, Boeing H, Wahrendorf J. Diet fat and sport activity as determinants for age at menarche. Am J Epidemiol 1993;138:217-24.
64. Petridou E, Syrigou E, Toupadaki N, Zavitsanos X, Willett W, Trichopoulos D. Determinants of age at menarche as early life predictors of breast cancer risk. Int J Cancer 1996;68: 193-8.
65. Sherman B, Wallace R, Bean J, Schlabaugh L. Relationship of body weight to menarcheal and menopausal age: implications for breast cancer risk. J Clin Endocrinol Metab 1981; 52:488.
66. Pike MC, Spicer OV, Dahmoush L, Press MF. Estrogens, progestins, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993;15:17-35.
67. Stallone DD. The influence of obesity and its treatment on the immune system. Nutr Rev 1994;52:37-50.
68. Blair SN. Evidence for success of exercise in weight loss and control. Ann Intern Med 1993;119:702-6.
69. Kumar NB, Lyman GH, Allen K, Cox CE, Schapira DV. Timing of weight gain and breast cancer risk. Cancer 1995;76: 243-9.
70. Ziegler RG, Hoover RN, Nomura AM, West DW, Wu AH, Pike MC, et al. Relative weight, weight change, height, and breast cancer risk in Asian-American women. J Natl Cancer Inst 1996;88:650-60.
71. DeWaard F. Recent time trends in breast cancer incidence. Prev Med 1978;7:160-7.
72. Sellers TA, Yushi LN, Potter JD, Kaye SA, Nelson CL, McGovern PG, et al. Effect of family history, body-fat distribution, and reproductive factors on the risk of postmenopausal breast cancer. N Engl J Med 1992;326:1323-9.
73. den Tonkelaar I, Seidell JC, Collette HJ. Body fat distribution in relation to breast cancer in women participating in the DOM-project. Breast Cancer Res Treat 1995;34:55-61.
74. Ng EH, Gao F, Ji CY, Ho GH, Soc KC. Risk factors for breast carcinoma in Singaporean Chinese women: the role of central obesity. Cancer 1997;80:725-31.
75. Despres JP, Pouliot MC, Moorjani S, Nadeau A, Tremblay A, Lupien PJ, et al. Loss of abdominal fat and metabolic response to exercise training in obese women. Am J Physiol 1991;261(2 Pt 1):E159-67.
76. Morganti CM, Nelson ME, Fiatarone MA, Dallal GE, Economos CD, Crawford BM, et al. Strength improvements with 1 year of progressive resistance training in older women. Med Sci Sports Exerc 1995;27:906-12.
77. Cheney CL, Mahloch J, Freeny P. Computerized tomography assessment of women with weight changes associated with adjuvant treatment for breast cancer. Am J Clin Nutr 1997; 66:141-6.
78. Demark-Wahnefried W, Hars V, Conaway MR, Havlin K, Rimer BK, McElveen G, et al. Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant. Am J Clin Nutr 1997;65:1495-501.
79. Albanes D, Blair A, Taylor PR. Physical activity and risk of cancer in the NHANES I population. Am J Public Health 1989;79:744-50.
80. DeStavola BL, Wang DY, Allen DS, Giaconi J, Fentiman IS, Reed MJ, et al. The association of height, weight, menstrual and reproductive events with breast cancer: results from two prospective studies on the island of Guersey (United Kingdom). Cancer Causes Control 1993;4:31-40.
81. Freni SC, Eberhardt MS, Turturro A, Hine RJ. Anthropometric measures and metabolic rate in association with risk o breast cancer (United States). Cancer Causes Control 1996; 3:358-65.
82. van den Brandt PA, Dirx MJ, Ronckers CM, van den Hoogen P, Goldbohm RA. Height, weight change, and postmenopausal breast cancer risk: the Netherlands Cohort Study. Cancer Causes Control 1997;8:39-47.
83. Yong LC, Brown CC, Schatzkin A, Schairer C. Prospective study of relative weight and risk of breast cancer: the Breast Cancer Detection Demonstration Project follow-up study. Am J Epidemiol 1996;143:985-95.
84. Zhang Y, Rosenberg L, Colton T, Cupples LA, Palmer JR, Strom BL, et al. Adult eight and risk of breast cancer among white women in a case-control study. Am J Epidemiol 1996; 143:1123-8.
85. Ziegler RG. Anthropometry and breast cancer. J Nutr 1997; 127(5 Suppl):924S-8S.
86. MacMahon B, Trichopoulos D, Brown J, Andersen AP, Aoki K, Cole P, et al. Age at menarche, probability of ovulation and breast cancer risk. Int J Cancer 1982;29:13-6.
87. Whiteside TL, Letessier E, Hirabayashi H, Vitolo D, Bryant J, Barnmes L, et al. Evidence for local and systemic activation of immune cells by peritoneum-oral injections of interleukin 2 in patients with advanced squamous cells carcinoma of the head and neck. Cancer Res 1993;53:5654-61.
88. Yoshino I, Yano T, Murata M, Ishida T, Sugimachi K, Kimura G. Tumor-reactive T cells accumulate in lung cancer tissues but fail to respond to tumor cell-derived factor. Cancer Res 1992;52:775.
89. Young MRI. Eicosanoids and the immunology of cancer. Cancer Metastasis Rev 1994;13:337.
90. Stewart TH, Hollinshead AC, Raman S. Tumor dormancy: initiation, maintenance and termination in animals and humans. Can J Surg 1991;34:321.
91. Gorelik E, Wiltrout R, Okumura K, Habu S, Herberman RB. Role of NK cells in the control of metastatic spread and growth of tumour cells in mice. Int J Cancer 1982;30:107-14.
92. Hanna N, Fidler IJ. The role of natural killer cells in the destruction of tumour emboli. J Natl Cancer Inst 1981;65: 801-10.
93. Hoffman-Goetz L, Pedersen BK. Exercise and the immune system: a model of the stress response? Immunol Today 1994;15:382-7.
94. Brines R, Hoffman-Goetz L, Pedersen BK. Can you exercise to make your immune system fitter? Immunol Today 1996; 17:252-3.
95. Pedersen BK Tvede N, Christensen LD, Klarlund K, Kragbak S, Halkjr-Kristensen J. Natural killer cell activity in peripheral blood of highly trained and untrained persons. Int J Sports Med 1989;10:129-31.
96. Tvede N, Steensberg J, Baslund B, Halkjzr-Kristensen J, Pedersen BK. Cellular immunity in highly trained elite racing cyclists during periods of training with high and low intensity. Scand J Med Sci Sports 1991;1:163-6.
97. Nieman DC, Henson DA, Gusewitch G, Warren BI, Dotson RC, Butterworth DE, et al. Physical activity and immune function in elderly women. Med Sci Sports Exerc 1993;25: 823-31.
98. Crist DM, Mackinnon LT, Thompson RF, Atterbom HA, Egan PA. Physical exercise increases natural cellular-mediated tumor cytotoxicity in elderly women. Gerontology 1989; 35:66-71.
99. Hoffman-Goetz L, Simpson JR, Cipp N, Arumugam Y, Houston ME. Lymphocyte subset responses to repeated submaximal exercise in men. J Appl Physiol 1990;68:1069-74.
100. Hoffman-Goetz L, May KM, Arumugam Y. Exercise training and mouse mammary tumor metastasis. Anticancer Res 1994;14:2627-32.
101. MacNeil B, Hoffman-Goetz L. Chronic exercise enhances in vivo and in vitro cytotoxicity mechanisms of natural immunity in mice. J Appl Physiol 1993;74:388-95.
102. Woods JA, Davis JM, Mayer EP, Ghaffar A, Pate RR. Effects of exercise on macrophage activation for antitumor cytotoxicity. J Appl Physiol 1994;76:2177-85.
103. Seaman WB Gindhart TD. Effect of estrogen on natural killer cells. Arthritis Rheum 1979;22:1234-40.
104. Hanna N, Schneider M. Enhancement of tumor metastasis and suppression of natural killer cell activity by β-estradiol treatment. J Immunol 1983;130:974-80.
105. Lewis CE, McGee JO'D. Natural killer cells in tumor biology. In: Lewis CE, McGee J O'D, editors. The natural killer cell. New York: IRL Press at Oxford University Press, 1992:175-203.
106. Levy SM, Herberman RB, Whiteside T, Sanzo K, Lee J, Kirkwood J. Perceived social support and tumour estrogen/ progesterone receptor status as predictors of natural killer cell activity in breast cancer patients. Psychosom Med 1990; 52:73-85.